| - |
How Synaptic Activity Protects Neurons
Scientists have identified a key signalling pathway that could protect areas of the brain at risk of damage from ageing and neurodegenerative diseases.
|
| - |
A New Therapy Of Cystic Fibrosis
A potential treatment for cystic fibrosis has been identified in mice.
|
| - |
The Best Of Both Worlds
The creation of a combined positron emission tomography (PET) and magnetic resonance imaging (MRI) scanner is reported online.
|
| - |
Therapeutic Cloning Treats Neurodegenerative Disease
Therapeutic cloning can be used to treat Parkinson's disease in mice.
|
| - |
Colorectal Cancer Risk Variants
Three new variants are associated with increased risk of colorectal cancer.
|
| - |
New Genetic Risk Factors For Type 2 Diabetes
At least six regions of the genome harbor variants that predispose to type 2 diabetes.
|
| - |
RNA Trojan Horses Zero In On Liver Cirrhosis
Using vitamin A to target the cells that cause liver cirrhosis may improve the treatment of the disease.
|
| - |
Route To Thwarting Skin Cancer
A paper has identified how the cells in epithelial tumours signal to one another in order to keep the population of rogue stem cells topped up.
|
| - |
Moving In On Drug Resistance
A paper in reveals a mechanism of how antifungal drugs have the unwanted effect of boosting the fungus' arsenal of pumps used to fight them off.
|
| - |
Smoking Receptors Mirror Lung Cancer Genes
A region on chromosome 15 that hosts three nicotine receptor subunit genes is associated with risk of lung cancer.
|
| - |
MicroRNA Silencing In Non-Human Primates
Researchers have effectively silenced microRNAs (miRNAs) in monkeys for the first time, targeting a liver-specific miRNA and reducing blood cholesterol as a result.
|
| - |
Genetic Blindness Treatments Emphasize Immune Role
A promising treatment for age-related macular degeneration - responsible for up to 50 million cases of blindness worldwide - works by a more general mechanism than had previously been thought.
|
| - |
Novel Fullerene Shows Potential For Secondary Progressive Multiple Sclerosis
A water-soluble fullerene-NMDA receptor antagonist hybrid prevented disease progression in an animal model, by protecting against axonal loss and demyelination.
|